RBM3 as a marker for malignant melanoma prognosis

Details for Australian Patent Application No. 2009339802 (hide)

Owner Atlas Antibodies AB

Inventors Uhlen, Mathias; Ponten, Fredrik; Jirstrom, Karin

Agent Pizzeys

Pub. Number AU-A-2009339802

PCT Pub. Number WO2010/091763

Priority 61/169,963 16.04.09 US; PCT/ SE2009/000091 16.02.09 SE; 09158084.5 16.04.09 EP; 09167847.4 13.08.09 EP; 61/233,769 13.08.09 US

Filing date 17 December 2009

Wipo publication date 19 August 2010

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/091763 Priority application(s): WO2010/091763

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009339804-Device and method for drying a tissue paper web using steam recapture

2009339714-Wind turbine generator, method of controlling the same, and wind turbine generating system